Font Size

cladribine (cont.)

What should I discuss with my healthcare provider before receiving cladribine (Cladribine Novaplus, Leustatin)?

You should not use this medication if you are allergic to it.

To make sure cladribine is safe for you, tell your doctor if you have liver or kidney disease, or a bone marrow problem.

FDA pregnancy category D. Do not use cladribine if you are pregnant. It could harm the unborn baby. Use effective birth control, and tell your doctor if you become pregnant during treatment.

It is not known whether cladribine passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are receiving cladribine.

How is cladribine given (Cladribine Novaplus, Leustatin)?

Cladribine is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting.

Cladribine must be given slowly through an IV infusion, and you will receive it around the clock for 7 days in a row. Your doctor will determine how many 7- day treatments you will receive and how often.

You may receive other medications to help prevent certain side effects of cladribine.

Cladribine can lower blood cells that help your body fight infections and help your blood to clot. Your blood will need to be tested often. Your cancer treatments may be delayed based on the results of these tests. Visit your doctor regularly.

Contact your doctor at once if you develop signs of infection such as fever, chills, sore throat, flu symptoms, cough with yellow or green mucus, loss of appetite, mouth sores, unusual weakness.

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Identifier Tool

Need help identifying pills and medications?
Use the pill finder tool on RxList.

Medical Dictionary